CP-615,003
CP-615,003 is a drug which acts as a subtype-selective partial agonist at GABA A receptors, and was developed by Pfizer as a potential anxiolytic; however, poor blood–brain barrier penetration make it primarily useful as a research ligand.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
CP-615,003 is a drug which acts as a subtype-selective partial agonist at GABA A receptors, and was developed by Pfizer as a potential anxiolytic; however, poor blood–brain barrier penetration make it primarily useful as a research ligand.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1337854944 under CC BY-SA 4.0; modifications have been made.